This study is being done to help better understand how the gut and skin bacteria of the body change when people with acne are treated with Sarecycline or Doxycycline. The bacteria in the gut and on the skin will be studied to see how each treatment may affect them and whether they change the profile of the bacteria that is present.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
One tablet by mouth (weight based dosing at 1.5 mg/kg and rounded to the closest tablet dose at either 60 mg, 100mg, or 150 mg tablet) once a day with food and a full glass of water (about 8 ounces)
100 mg twice daily with food and a full glass of water (about 8 ounces)
Integrative Research Institute
Sacramento, California, United States
RECRUITINGChange in the relative abundance of tetracycline-resistant bacteria in the gut microbiome
Assessing change in the relative abundance of tetracycline resistant bacteria in the gut microbiome following treatment.
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in the relative abundance of fungi/yeast in the gut microbiome
Assessing change in the relative abundance of fungi/yeast in the gut microbiome following treatment.
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in inflammatory and non-inflammatory lesions
Assesing change in inflammatory and non-inflammatory lesions.
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in the diversity of the gut microbiome: Shannon Diversity
Assessing the change in Alpha Diversity of the gut microbiome via Shannon Diversity
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in investigator global assessment of acne
Change in investigator global assessment of acne
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in relative abundance of short chain fatty acid production genes
Assessing change in relative abundance of short chain fatty acid production genes upon gut microbiome analysis.
Time frame: From enrollment to the end of treatment at 4 weeks.
Change in skin microbiome relative abundance
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessing change in the relative abundance of the skin microbiome via Shannon Diversity.
Time frame: From enrollment to the end of treatment at 8 weeks.
Change in the skin microbiome relative abundance of fungi/yeast
Assessing change in the relative abundance of fungi/yeast in the skin microbiome.
Time frame: From enrollement to the end of treatment at 4 weeks.